NCT00176930 · OUTCOME
Number of Participants Experiencing Engraftment Failure
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Day 42
What was measured
Graft failure is defined as not accepting donated cells. The donated cells do not make the new white blood cells, red blood cells and platelets.
Groups in this outcome
PBSC: No TBI
Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Peripheral Blood Stem Cells (PBSC) as a source of transplant
Marrow : No TBI
Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Bone Marrow as a source of stem cell transplant
UCB : No TBI
Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Umbilical Cord Blood (UCB) as a source of stem cell transplant
UCB : No TBI/Bu/Cy/ATG
Patients who receives Umbilical Cord Blood (UCB) as a source of transplant and who have not had chemotherapy in the prior 3 months receives ATG in addition to cyclophosphamide, Busulfan preparative regimen
PBSC
Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Peripheral blood stem cells as a source of transplant
Marrow
Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Bone Marrow as a source of stem cell transplant
Umbilical Cord Blood
Patients receiving cyclophosphamide, Total Body Irradiation (TBI), and Umbilical Cord Blood (UCB) as a source of stem cell transplant
Co-Enroll From MT0403
Patients receiving cyclophosphamide, Total Body Irradiation (TBI) , CD4+CD25+ and Peripheral Blood Stem Cells (PBSC) as a source of transplant. These patients are co-enrolled on the MT2004-03 trial (NCT00725062)
| Group | Source count |
|---|---|
| PBSC: No TBI | 12 |
| Marrow : No TBI | 13 |
| UCB : No TBI | 1 |
| UCB : No TBI/Bu/Cy/ATG | 1 |
| PBSC | 213 |
| Marrow | 85 |
| Umbilical Cord Blood | 2 |
| Co-Enroll From MT0403 | 2 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| PBSC: No TBI | 0 | Not reported | Not reported | Not reported | Not reported |
| Marrow : No TBI | 0 | Not reported | Not reported | Not reported | Not reported |
| UCB : No TBI | 0 | Not reported | Not reported | Not reported | Not reported |
| UCB : No TBI/Bu/Cy/ATG | 0 | Not reported | Not reported | Not reported | Not reported |
| PBSC | 1 | Not reported | Not reported | Not reported | Not reported |
| Marrow | 0 | Not reported | Not reported | Not reported | Not reported |
| Umbilical Cord Blood | 0 | Not reported | Not reported | Not reported | Not reported |
| Co-Enroll From MT0403 | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 1
- group Id
- OG005
- value
- 0
- group Id
- OG006
- value
- 0
- group Id
- OG007
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 12
- group Id
- OG001
- value
- 13
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 213
- group Id
- OG005
- value
- 85
- group Id
- OG006
- value
- 2
- group Id
- OG007
- value
- 2
- units
- Participants
- description
- Graft failure is defined as not accepting donated cells. The donated cells do not make the new white blood cells, red blood cells and platelets.
- groups
- description
- Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Peripheral Blood Stem Cells (PBSC) as a source of transplant
- id
- OG000
- title
- PBSC: No TBI
- description
- Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Bone Marrow as a source of stem cell transplant
- id
- OG001
- title
- Marrow : No TBI
- description
- Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Umbilical Cord Blood (UCB) as a source of stem cell transplant
- id
- OG002
- title
- UCB : No TBI
- description
- Patients who receives Umbilical Cord Blood (UCB) as a source of transplant and who have not had chemotherapy in the prior 3 months receives ATG in addition to cyclophosphamide, Busulfan preparative regimen
- id
- OG003
- title
- UCB : No TBI/Bu/Cy/ATG
- description
- Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Peripheral blood stem cells as a source of transplant
- id
- OG004
- title
- PBSC
- description
- Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Bone Marrow as a source of stem cell transplant
- id
- OG005
- title
- Marrow
- description
- Patients receiving cyclophosphamide, Total Body Irradiation (TBI), and Umbilical Cord Blood (UCB) as a source of stem cell transplant
- id
- OG006
- title
- Umbilical Cord Blood
- description
- Patients receiving cyclophosphamide, Total Body Irradiation (TBI) , CD4+CD25+ and Peripheral Blood Stem Cells (PBSC) as a source of transplant. These patients are co-enrolled on the MT2004-03 trial (NCT00725062)
- id
- OG007
- title
- Co-Enroll From MT0403
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Day 42
- title
- Number of Participants Experiencing Engraftment Failure
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle